Giant stepBelgian health minister Maggie de Block, one of the instigators of Beneluxa, said in a Thursday statement that this demonstrated that countries can jointly negotiate the reimbursement of orphan drugs.
Patient populationThe list price for Spinraza is €83,300 per injection, and six injections are needed in the first year - at a cost of €499,800 - and three per year subsequently, at a cost of €249,900.
Expanding BeneluxaThe Beneluxa initiative, initiated by Belgium and the Netherlands to give health agencies better leverage in negotiations with international drug firms, has expanded to embrace Luxembourg, Austria and, most recently, Ireland (APMHE 58650).
TRY APM HEALTH EUROPE AND GET ACCESS TO THE FULL CONTENT
Interviews with KOLs/senior executives amongst the Regulators, Payers, Health, Medical & Pharmaceutical organisations
Events coverage with a unique focus on Market Access & sustainability of healthcare systems
6 European bureaus : Berlin, Brussels, London, Madrid, Milan & Paris
Ask for a Free trial and get access to our last stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.